NCT02931929View on ClinicalTrials.gov

MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

April 9, 2019

Study Completion Date

April 9, 2019

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

68Ga-NeoBOMB1, 2-vial kit

intravenous application of a radiopharmaceutical for Positron Emission tomography (PET)

Trial Locations (1)

6020

Medical University Innsbruck, Innsbruck

All Listed Sponsors
collaborator

European Union

OTHER

lead

Medical University Innsbruck

OTHER

NCT02931929 - MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT | Biotech Hunter | Biotech Hunter